Autonomix selected to present new long-term pain mitigation data at SSO 2026

Autonomix (AMIX) Medical announced that Clarke Wilkirson, PhD, Clinical Development Engineer II, will present new long-term clinical data at the Society of Surgical Oncology, SSO, 2026 Annual Meeting, happening March 5-7, 2026, in Phoenix, Arizona. The presentation, titled “Pain Mitigation in Pancreatic Adenocarcinoma: A Long-Term Analysis of Denervation via Transvascular RF Energy-Based Ablation,” has been accepted as an oral podium presentation. Dr. Wilkirson will deliver a five-minute presentation followed by a two-minute question-and-answer session, highlighting the potential of Autonomix Medical’s minimally invasive transvascular RF energy-based approach to address chronic pain in pancreatic cancer patients.